Canadian application, no grantCanada
Use of inhibitors of progesteron receptor for treating cancer
CA 2423013 A1 · Owner: Fuhrmann, Ulrike · Inventors: Lichtner, Rosemarie; Fuhrmann, Ulrike
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of progesterone receptor inhibitors for inhibition of growth-factor-dependency of tumor cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 17, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 17, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 17, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 17, 2001
GrantedNo grant recorded
Term endedOctober 17, 2021
Patent numberCA 2423013 A1
Classification (IPC)A61K31/56 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.